Our previous research found that knockdown of PRMT5 could increase the number and function of CD8+ T cells, and it has been confirmed that the absence of PRMT5 reprograms the T cell-mediated response by regulating the expression of PD-L1, promoting the anti-tumor immune response in cervical cancer [8]. This evidence concerns the gene CD8A and cervical carcinoma.